These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3690805)

  • 1. Serum tamoxifen concentrations in the athymic nude mouse after three methods of administration.
    DeGregorio MW; Wilbur BJ; Coronado E; Osborne CK
    Cancer Chemother Pharmacol; 1987; 20(4):316-8. PubMed ID: 3690805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor and serum tamoxifen concentrations in the athymic nude mouse.
    DeGregorio MW; Coronado E; Osborne CK
    Cancer Chemother Pharmacol; 1989; 23(2):68-70. PubMed ID: 2910513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.
    Gottardis MM; Ricchio ME; Satyaswaroop PG; Jordan VC
    Cancer Res; 1990 Jun; 50(11):3189-92. PubMed ID: 2334915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen administration and metabolism in nude mice and nude rats.
    Kisanga ER; Gjerde J; Schjøtt J; Mellgren G; Lien EA
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):361-7. PubMed ID: 12711024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.
    Long BJ; Jelovac D; Handratta V; Thiantanawat A; MacPherson N; Ragaz J; Goloubeva OG; Brodie AM
    J Natl Cancer Inst; 2004 Mar; 96(6):456-65. PubMed ID: 15026471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK; Hobbs K; Clark GM
    Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible control of oestradiol-stimulated growth of MCF-7 tumours by tamoxifen in the athymic mouse.
    Iino Y; Wolf DM; Langan-Fahey SM; Johnson DA; Ricchio M; Thompson ME; Jordan VC
    Br J Cancer; 1991 Dec; 64(6):1019-24. PubMed ID: 1764361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and urine levels of tamoxifen and its metabolites in patients with advanced breast cancer after a loading dose and at steady-state levels.
    de Vos D; Slee PH; Briggs RJ; Stevenson D
    Cancer Chemother Pharmacol; 1998; 42(6):512-4. PubMed ID: 9788580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen.
    Gottardis MM; Robinson SP; Jordan VC
    J Steroid Biochem; 1988; 30(1-6):311-4. PubMed ID: 3386259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potentiation of 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity by tamoxifen in female CD1 mice.
    MacKenzie SA; Thomas T; Umbreit TH; Gallo MA
    Toxicol Appl Pharmacol; 1992 Sep; 116(1):101-9. PubMed ID: 1529443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.
    Jordan VC; Gottardis MM; Robinson SP; Friedl A
    J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of 4-hydroxytamoxifen in mouse plasma in the pg/mL range by gradient capillary liquid chromatography/tandem mass spectrometry.
    Plumb RS; Warwick H; Higton D; Dear GJ; Mallett DN
    Rapid Commun Mass Spectrom; 2001; 15(4):297-303. PubMed ID: 11223962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity, distribution, and metabolism of 13-cis-retinoic acid as a single agent or in combination with tamoxifen in established human MCF-7 xenografts in mice.
    Conley BA; Ramsland TS; Sentz DL; Wu S; Rosen DM; Wollman M; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 43(3):183-97. PubMed ID: 9923548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of hepatic drug-metabolising enzymes and tamoxifen metabolite profile in relation to administration route during low-dose treatment in nude rats.
    Kisanga ER; Moi LL; Gjerde J; Mellgren G; Lien EA
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):489-98. PubMed ID: 15876414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.
    Wolf DM; Langan-Fahey SM; Parker CJ; McCague R; Jordan VC
    J Natl Cancer Inst; 1993 May; 85(10):806-12. PubMed ID: 8487325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care.
    Jager NG; Rosing H; Schellens JH; Linn SC; Beijnen JH
    Breast Cancer Res Treat; 2014 Feb; 143(3):477-83. PubMed ID: 24390246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen.
    Abe-Hashimoto J; Kikuchi T; Matsumoto T; Nishii Y; Ogata E; Ikeda K
    Cancer Res; 1993 Jun; 53(11):2534-7. PubMed ID: 8495416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.
    Osborne CK; Coronado E; Allred DC; Wiebe V; DeGregorio M
    J Natl Cancer Inst; 1991 Oct; 83(20):1477-82. PubMed ID: 1920493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.